Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial...
34 insider purchases on record · latest filing 2026-03-11.
Insiders have also filed 9 sale transactions at ENTX.